Renin-angiotensin system may trigger kidney damage in NOD mice

Abstract

Diabetic nephropathy is a complication of diabetes and one of the main causes of end-stage renal disease. A possible causal link between renin—angiotensin aldosterone system (RAAS) and diabetes is widely recognized but the mechanisms by which the RAAS may lead to this complication remains unclear. The aim of this study was to evaluate angiotensin-I converting enzyme (ACE) activity and expression in numerous tissues, especially kidney, of non-obese diabetic mouse. Kidney, lung, pancreas, heart, liver and adrenal tissues from diabetic and control female NOD mice were homogenized for measurement of ACE activity, SDS-PAGE and Western blotting for ACE and ACE2, immunohistochemistry for ACE and angiotensins I, II and 1-7 and bradykinin quantification. ACE activity was higher in kidney, lung and adrenal tissue of diabetic mice compared with control mice. In pancreas, activity was decreased in the diabetic group. Western blotting analysis indicated that both groups presented ACE isoforms with molecular weights of 142 and 69 kDa and a decrease in ACE2 protein expression. Angiotensin concentrations were not altered within groups, although bradykinin levels were higher in diabetic mice. The immunohistochemical study in kidney showed an increase in tubular ACE expression. Our results show that the RAAS is affected by diabetes and the elevated ACE/ACE2 ratio may contribute to renal damage.

Keywords

ACE diabetes NOD mouse ACE2 diabetic nephropathy

Get full access to this article

View all access options for this article.

References

Sperandeo M. , D’Amico G. , Varriale A. , Sperandeo G. , Annese MA , and Correra M. [Pulsed-wave color Doppler echography of the intrarenal vessels in patients with insulin-dependent diabetes mellitus and incipient nephropathy]. Arch Ital Urol Androl 1996; 68(5 Suppl): 183-187.

Bouhanick B. , Laboureau-Soares Barbosa S. , and Marre M. [Hypertension and diabetes]. Arch Mal Coeur Vaiss 2000; 93(11 Suppl): 1429-1434.

Huang W. , Gallois Y. , Bouby N. , et al. Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse. Proc Natl Acad Sci U S A 2001; 98: 13330-13334.

Yang HY , Erdos EG Second kininase in human blood plasma. Nature 1967; 215: 1402-1403.

Wei L. , Alhenc-Gelas F. , Corvol P. , and Clauser E. The two homologous domains of human angiotensin I-converting enzyme are both catalytically active. J Biol Chem 1991; 266: 9002-9008.

Jaspard E. , Wei L. , and Alhenc-Gelas F. Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kininase II). Studies with bradykinin and other natural peptides. J Biol Chem 1993 ; 268: 9496-9503.

Deddish PA , Wang J. , Michel B. , et al. Naturally occurring active N-domain of human angiotensin I-converting enzyme. Proc Natl Acad Sci U S A 1994; 91: 7807-7811.

Rousseau A. , Michaud A. , Chauvet MT , Lenfant M. , and Corvol P. The hemoregulatory peptide N-acetyl-Ser-Asp-Lys-Pro is a natural and specific substrate of the N-terminal active site of human angiotensin-converting enzyme . J Biol Chem 1995; 270: 3656-3661.

Ehlers MR , Fox EA , Strydom DJ , Riordan JF Molecular cloning of human testicular angiotensin-converting enzyme: the testis isozyme is identical to the C-terminal half of endothelial angiotensin-converting enzyme. Proc Natl Acad Sci U S A 1989; 86: 7741-7745.

10.

Erdos EG , Skidgel RA The angiotensin I-converting enzyme. Lab Invest 1987; 56: 345-348.

11.

Casarini DE , Carmona AK , Plavnik FL , Zanella MT , Juliano L. , and Ribeiro AB Calcium channel blockers as inhibitors of angiotensin I-converting enzyme. Hypertension 1995; 26: 1145-1148.

12.

Casarini DE , Plavinik FL , Zanella MT , et al. Angiotensin converting enzymes from human urine of mild hypertensive untreated patients resemble the N-terminal fragment of human angiotensin I-converting enzyme. Int J Biochem Cell Biol 2001; 33: 75-85.

13.

Erdos EG Angiotensin I converting enzyme and the changes in our concepts through the years. Lewis K. Dahl memorial lecture. Hypertension 1990; 16: 363-370.

14.

Iborra FJ , Jackson DA , and Cook PR Coupled transcription and translation within nuclei of mammalian cells. Science 2001; 293: 1139-1142.

15.

Kokubu T. , Kato I. , Nishimura K. , Hiwada K. , and Ueda E. Angiotensin I-converting enzyme in human urine. Clin Chim Acta 1978; 89: 375-379.

16.

Camargo de Andrade MC , Di Marco GS , de Paulo Castro Teixeira V. , et al. Expression and localization of N-domain ANG I-converting enzymes in mesangial cells in culture from spontaneously hypertensive rats. Am J Physiol Renal Physiol 2006; 290: F364-375.

17.

Oliveira MA , Carvalho MH , Nigro D. , Passaglia Rde C. , and Fortes ZB Angiotensin-(1-7) and bradykinin interaction in diabetes mellitus: in vivo study. Peptides 2002; 23: 1449-1455.

18.

Santos RA , Campagnole-Santos MJ , and Andrade SP Angiotensin-(1-7): an update. Regul Pept 2000 ; 91: 45-62.

19.

Paula RD , Lima CV , Khosla MC , and Santos RA Angiotensin-(1-7) potentiates the hypotensive effect of bradykinin in conscious rats. Hypertension 1995; 26: 1154-1159.

20.

Brosnihan KB , Li P. , and Ferrario CM Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension 1996; 27: 523-528.

21.

Oliveira MA , Fortes ZB , Santos RA , Kosla MC , and De Carvalho MH Synergistic effect of angiotensin-(1-7) on bradykinin arteriolar dilation in vivo. Peptides 1999; 20: 1195-201.

22.

Ueda S. , Masumori-Maemoto S. , Wada A. , Ishii M. , Brosnihan KB , and Umemura S. Angiotensin(1-7) potentiates bradykinin-induced vasodilatation in man. J Hypertens 2001; 19: 2001-2009.

23.

Marques GD , Quinto BM , Plavinik FL , Krieger JE , Marson O. , and Casarini DE N-domain angiotensin I-converting enzyme with 80 kDa as a possible genetic marker of hypertension. Hypertension 2003; 42: 693-701.

24.

Makino S. , Kunimoto K. , Muraoka Y. , Mizushima Y. , Katagiri K. , and Tochino Y. Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu 1980; 29: 1-13.

25.

Bradford MM A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.

26.

Oliveira EM , Santos RA , and Krieger JE Standardization of a fluorimetric assay for the determination of tissue angiotensin-converting enzyme activity in rats. Braz J Med Biol Res 2000; 33: 755-764.

27.

Laemmli UK Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.

28.

Prieto-Carrasquero MC , Botros FT , Pagan J. , et al. Collecting duct renin is upregulated in both kidneys of 2-kidney, 1-clip goldblatt hypertensive rats. Hypertension 2008; 51: 1590-1596.

29.

Vidotti DB , Casarini DE , Cristovam PC , Leite CA , Schor N. , and Boim MA High glucose concentration stimulates intracellular renin activity and angiotensin II generation in rat mesangial cells. Am J Physiol Renal Physiol 2004; 286: F1039-1045.

30.

Colucci JA , Candido GO , Di Marco GS , Pacheco-Silva A. , Irigoyen MC , and Casarini DE Effects of diabetes over renin angiotensin system enzymes and peptides of non obese diabetic mice mesangial cells. J Hypertens 2008; 26 (suppl 1): S520. 31. Wysocki J. , Ye M. , Soler MJ , et al. ACE and ACE2 activity in diabetic mice. Diabetes 2006 ; 55: 2132-2139.

31.

Maeda M. , Yabuki A. , Suzuki S. , Matsumoto M. , Taniguchi K. , and Nishinakagawa H. Renal lesions in spontaneous insulin-dependent diabetes mellitus in the non-obese diabetic mouse: acute phase of diabetes . Vet Pathol 2003; 40: 187-195.

32.

Allen TJ , Cooper ME , and Lan HY Use of genetic mouse models in the study of diabetic nephropathy. Curr Diab Rep 2004; 4: 435-440.

33.

Ronchi FA , Irigoyen MC , and Casarini DE Association of somatic and N-domain angiotensin-converting enzymes from Wistar rat tissue with renal dysfunction in diabetes mellitus. J Renin Angiotensin Aldosterone Syst 2007; 8: 34-41.

34.

Smithies O. , Kim HS , Takahashi N. , and Edgell MH Importance of quantitative genetic variations in the etiology of hypertension. Kidney Int 2000; 58: 2265-2280.

35.

Campbell DJ , Kladis A. , and Duncan AM Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides. Hypertension 1994; 23: 439-449.

36.

Donoghue M. , Hsieh F. , Baronas E. , et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 2000; 87: E1-9.

37.

Tipnis SR , Hooper NM , Hyde R. , Karran E. , Christie G. , and Turner AJ A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 2000; 275: 33238-33243.

38.

Tikellis C. , Johnston CI , Forbes JM , et al. Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy. Hypertension 2003; 41: 392-397.

39.

Soler MJ , Wysocki J. , Ye M. , Lloveras J. , Kanwar Y. , and Batlle D. ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice. Kidney Int 2007; 72: 614-623.

40.

Ye M. , Wysocki J. , William J. , Soler MJ , Cokic I. , and Batlle D. Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes . J Am Soc Nephrol 2006; 17: 3067-3075.

41.

Ye M. , Wysocki J. , Naaz P. , Salabat MR , LaPointe MS , and Batlle D.

Increased ACE 2 and decreased ACE protein in renal tubules from diabetic mice: a renoprotective combination?

Hypertension 2004; 43: 1120-1125.

42.

Reich HN , Oudit GY , Penninger JM , Scholey JW , and Herzenberg AM Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease. Kidney Int 2008; 74: 1610-1616.

43.

Campbell DJ , Kelly DJ , Wilkinson-Berka JL , Cooper ME , and Skinner SL Increased bradykinin and "normal" angiotensin peptide levels in diabetic Sprague-Dawley and transgenic (mRen-2)27 rats. Kidney Int 1999; 56: 211-221.

44.

Erman A. , van Dyk DJ , Chen-Gal B. , Giler ID , Rosenfeld JB , and Boner G. Angiotensin converting enzyme activity in the serum, lung and kidney of diabetic rats. Eur J Clin Invest 1993; 23: 615-620.

45.

Pueyo ME , Challah M. , Gauguier D. , et al. Transforming growth factor-beta 1 production is correlated with genetically determined ACE expression in congenic rats: a possible link between ACE genotype and diabetic nephropathy. Diabetes 2004; 53: 1111-1118.

46.

Fredersdorf S. , Endemann DH , Luchner A. , et al. Increased aldosterone levels in a model of Type 2 Diabetes Mellitus. Exp Clin Endocrinol Diabetes 2009; 117: 15-20.

47.

Gross V. , Tank J. , Partke HJ , et al. Cardiovascular autonomic regulation in Non-Obese Diabetic (NOD) mice. Auton Neurosci 2008; 138: 108-113.

48.

Moon JY , Jeong KH , Lee SH , Lee TW , Ihm CG , and Lim SJ Renal ACE and ACE2 expression in early diabetic rats. Nephron Exp Nephrol 2008; 110: e8-e16.

49.

Mizuiri S. , Hemmi H. , Arita M. , et al. Expression of ACE and ACE2 in individuals with diabetic kidney disease and healthy controls. Am J Kidney Dis 2008; 51: 613-623.